Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAIN
NCT00486759Phase 3Terminated
- Sponsor
- Roche
- Start
- Jul 2007
- Primary completion
- Nov 2011
- Modality
- Monoclonal Antibodies
- Countries
- 34
01
Overview
A Phase 3 trial of bevacizumab in diffuse large B-cell lymphoma (DLBCL), sponsored by Roche. Started Jul 2007; status: terminated.
02
Drugs
bevacizumab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00486759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486759.